skip to content

Sun Pharmaceuticals

Sun Pharmaceutical Industries Limited, operating as Sun Pharma, is a multinational pharmaceutical giant headquartered in Mumbai. A leading player in the global pharmaceutical landscape, Sun Pharma manufactures and distributes a wide array of pharmaceutical formulations and active pharmaceutical ingr...

Sun Pharmaceuticals Overview

Sun Pharmaceuticals Image Source : Wikipedia
  • Company type Public
  • Industry Pharmaceuticals
  • Founded 1983
  • Founders Dilip Shanghvi
  • Headquarters Mumbai, India
  • Area served Worldwide
  • Key people Dilip Shanghvi (MD)
  • Revenue ₹48,496 crore (US$5.5 billion) (FY24)
  • Net income ₹9,576 crore (US$1.1 billion) (FY24)
  • Number of employees 41,000+ (2023)
  • Website www.sunpharma.com

Related Other Pages:

Sun Pharmaceuticals history

Last Updated : 25/03/25, 11:13 PM
Sun Pharmaceutical Industries Ltd: A Pharmaceutical Giant Founded in 1983 by Dilip Shanghvi in Calcutta, Sun Pharmaceutical Industries has ascended to become a leading global pharmaceutical company. Initially launched with a modest portfolio of five psychiatry products and a small team, the company ...

SUN PHARMACEUTICALS NEWS

Sun Pharma shares tank 15%; m-cap dips by Rs 34,055 cr

July 22, 2015 2:00 am

As a part of the integration process with Ranbaxy, the company expects to incur certain integration charges in order to generate long-term synergies from this merger, Sun Pharma said on Monday.

Ranbaxy posts loss after write-offs on US bans

May 10, 2014 12:33 am

The Japan’s Daiichi Sankyo-owned firm made a provision of Rs 62.95 crore for inventory write-off and other costs.

Sun Pharmaceuticals to take 'appropriate action', after $4 bn Ranbaxy Laboratories deal stalled by AP High Court

May 04, 2014 12:01 am

Court has issued orders to maintain status quo on Sun Pharma, Ranbaxy Laboratories deal.

Sun Pharma shares gain more than 4% intraday after announcing plans to acquire Ranbaxy Laboratories

July 06, 2020 8:36 pm

Sun Pharma scrip was trading 1.43 % higher at Rs 580.10, while shares of Ranbaxy Laboratories were trading 5.14% lower at Rs 436.

Sun Pharmaceuticals shares gain on US FDA approval of schizophrenia drug

March 12, 2014 12:56 pm

FDA has posted approval for Sun Pharma's generic schizophrenia drug, Risperidone, on its website.

BSE Sensex extends losses for 2nd day,down 240 points

November 21, 2013 10:06 am

BSE Sensex had lost 255.69 points in previous session,fell further by 161.89 pts to 20,473.24.

Sun Pharma raises 2013-14 revenue outlook to 25%

November 14, 2013 10:41 am

Sun Pharma's quarterly net profit jumped 3.5 times to Rs 1,559.79 crore owing to a 46% rise in net sales.

BSE Sensex closes higher,ITC rises,Sun Pharmaceuticals shares hit all-time high

September 26, 2013 4:24 pm

BSE Sensex rose 0.18 percent,while the broader NSE Nifty ended up 0.14 percent.

BSE Sensex,NSE Nifty close lower,Reliance Industries shares drop

September 25, 2013 3:56 pm

Blue chip shares including Reliance Industries led the declines list.

Edition
Install the Express App for
a better experience
Featured
Trending Topics
News
Multimedia
Follow Us